Cardiovascular Pre-Operative Evaluation for Non-Cardiac Surgery Jessica Thom PGY-1.

Slides:



Advertisements
Similar presentations
الجامعة السورية الخاصة كلية الطب البشري قسم الجراحة Perioperative management of the high-risk surgical patient Dr. M.A.Kubtan, MD - FRCS.
Advertisements

Stenting Patients Needing Non-Cardiac Surgery
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery A Report of the American College of Cardiology/American.
Ryan Hampton January  Risks and benefits of surgery  Timing of surgery  Type of Surgery  Goal is to uncover undiagnosed problems or treat prior.
CARDIAC RISK ASSESSMENT FOR NONCARDIAC SURGERY JOHN HAMATY D.O. SOUTH JERSEY HEART GROUP SJHG.ORG.
Jacobi Ambulatory Care Service Medical Consultation: An Overview Lori A. Lemberg, MD Fall 2012.
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
PREOPERATIVE ASSESSMENT OF THE GERIATRIC PATIENT Cheryl Hinners M.D.
What is Cardiology Clearance? Sheilah Bernard, MD, FACC Director, Cardiac Amb Services Sheilah Bernard, MD, FACC Director, Cardiac Amb Services 9:30-10:00am.
Copyright ©2007 American College of Cardiology Foundation. Restrictions may apply. Fleisher, L. A. et al. J Am Coll Cardiol 2007;50:e159-e242 Cardiac evaluation.
CABG GUIDELINES SANJAY DRAVID, M.D.. INTRODUCTION ACC/AHA GUIDELINE UPDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (JACC 2004; 44: AND CIRCULATION.
Prescreening ä To optimize safety ä To permit the development of a sound and effective exercise prescription.
Focusing on the Surgical Patient with Cardiac Problems By Kate J. Morse, RN, ACNP-BC, CCRN Nursing2009, March ANCC contact hours Online:
Modalities of Cardiac Stress Test
Epidemiology of Noncardiac Surgery Dr. Mohammed Naser.
Risk Assessment for Perioperative Pulmonary Complications in Patients Undergoing Noncardiothoracic Surgery Joanne D. So, MS4 Tulane University School of.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Preoperative assessment
Perioperative Risk Assessment - Can You Get It Right?
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
ACC/AHA 2007 Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery Doris Lin, M.D.
Preoperative Cardiac Evaluation Jonathan Hastie January 31, 2006.
Optimizing the surgical patient Dana Doll D.O. Chair of Anesthesia St Michaels Hospital Stevens Point, WI.
1 Covenants of the Medical Home Neighborhood  How Primary Care Physicians and Specialists can “Choose Wisely”
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Arthur Stillman, M.D., Ph.D., PI Pamela Woodard, M.D., Study Co-chair Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic.
Cardioprotective Agents in the Total Joint Arthroplasty Patient: Are We Doing Enough? Eric Schwenk MD*, Kishor Gandhi MD MPH*, Javad Parvizi MD^, Eugene.
Perioperative Testing
C.H.T Dr.Salarifar 1 Tehran Heart Center Tehran University of Medical Sciences PCI VS CABG M. SALARIFAR, MD.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Ischemic heart disease. Indications and methods of surgical treatment. Surgery department №2.
New guidelines for CABG
Management of Stable Angina SIGN 96
Lecture Title: Lecture Title: Role of anesthesiologist in pre-operative period Lecturer name: Lecturer name: Prof. Ahmed Abdulmoemn Lecture Date:
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
- To understand the perioperative period term. - To understand the objectives of preoprative visit. - To identify the risk factors in anesthesia. - To.
3/99medslides.com1 Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery ACC/AHA Task Force JACC 1996; 27: Circulation 1996;
Locally Agreed Guidelines May Reduce Inappropriate Preoperative Echocardiography Requests Dr Sheila Carey Anaesthetic SpR Northern Deanery.
Perioperative and Consultative Medicine Pamela J. Pride MD, FHM Medical University of South Carolina 2/7/2012.
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
Pre-operative Cardiovascular Evaluation: Guidelines and More Eric A. Brody MD, FACC Medical Director, NA Cardiology and Medical Services Associate Professor.
Pre-operative Assessment of the Surgical Patient
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
Dr.Moallemy PREOPERATIVE EVALUATION AND MEDICATION AND RISK ASSESMENT Abas Moallemy,MD Assistant professor of Anesthesiology,Fellowship of pain,Hormozgan.
ACC/AHA 2006 guidelines on the management of PAD.
Preoperative Cardiac Evaluation
Indication Of Cardiac Consultation In Noncardiac Surgery.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Multivessel Coronary Artery Disease
Perioperative Cardiovascular Evaluation SooJoong Kim, MD, PhD. Department of Cardiology, Internal Medicine, Kyunghee University Medical Center.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Cardio-Pulmonary Pre Operative Risk Assessment Andy Shakespeare MD PGY2 Baylor Scott and White IM
Evaluation of the Cardiac Patient Before Non-Cardiac Surgery
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Developed in Collaboration with.
Segment 1 Perioperative Risk Assessment. Need Advice – How Low is Low Dear Consult Sages ; I need your help and guidance to provide better service to.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease by Stephan D. Fihn, Julius.
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
preoperative evaluation
Glenn N. Levine et al. JACC 2016;68:
New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery  Stephen.
Section V: Erectile dysfunction: The patients you see
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease  Glenn N. Levine, MD, FACC, FAHA,
Atlantic Cardiovascular Patient Outcomes Research Team
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Presentation transcript:

Cardiovascular Pre-Operative Evaluation for Non-Cardiac Surgery Jessica Thom PGY-1

2007 ACC/AHA Pre-Op Guidelines for Cardiovascular Evaluation and Care for Non-Cardiac Surgery

Heart disease and procedures 1.3 million Canadians (4.3%) reported to have heart disease The prevalence of heart disease increases with age The largest number of non-cardiac surgical procedures performed in patients aged 65 and older.

Methodology & Evidence Literature searches in PubMed, MEDLINE and Cochrane Library Searches limited to studies published in English between Reviewed 400 relevant new articles focused on perioperative risk for cardiac complications following non-cardiac surgery

Role of the consultant Review available patient data Obtain a pertinent history Perform a thorough physical examination Suggest preoperative tests/procedures or higher levels of post-op care Pre-op tests are generally only indicated if the information obtained will change treatment Be weary of solely focusing on the question at hand. Aim instead to provide a comprehensive evaluation of the patient’s risk

History Cardiac history: unstable/stable angina, prior MI, decompensated HF, arrhythmias, severe valvular disease, presence of pacemaker/ICD If cardiac disease is present: any recent change in symptoms? Evidence of associated diseases: DM, CKD, stroke, PVD, chronic pulmonary disease Record all medications (including herbals) Social habits: smoking history Determine the functional capacity As determined based on METS

What’s a MET?

What cardiac conditions should I work up and treat?

Physical Exam Vital signs General appearance Cardiac exam Pulmonary exam Examination of area undergoing surgery

Clinical risk factors for cardiac complications in non-cardiac surgery High risk surgery Ischemic heart disease Heart failure Diabetes Renal insufficiency – Pre-op creatinine > 2.0mg/DL (175 mmol/L) Previous stroke

Relative risks of surgical procedures Low risk: Opthalmologic procedures, superficial procedures, endoscopy, breast surgeries Intermediate risk: Orthopedic surgeries, intra- abdominal surgeries, intra-thoracic surgeries, ENT surgeries, prostate surgery, carotid endarterectomies High risk: All other vascular surgeries

Figure 1. Cardiac evaluation and care algorithm for noncardiac surgery based on active clinical conditions, known cardiovascular disease, or cardiac risk factors for patients 50 years of age or greater. *See Table 2 for active clinical conditions. †See Clas... Fleisher L A et al. Circulation 2007;116:e418-e500 Copyright © American Heart Association The all important algorithm

Additional Testing?

Role of a 12-lead EKG Indicated in: All patients undergoing vascular surgery Patients with at least 1 clinical risk factor undergoing intermediate risk surgery

Non-invasive stress testing Reasonable in patients with 3+ clinical risk factors and poor functional capacity (<4 METS) undergoing vascular surgery if it will change management (IIa) Consider in patients with 2+ clinical risk factors and poor functional capacity undergoing intermediate-risk surgery if it will change management (IIb)

Pre-op Coronary Revascularization with CABG or PCI Class I: In patients with acute STEMI In patients with high-risk unstable angina or NSTEMI In patients with stable angina who have: Significant left main disease 3-vessel disease (survival benefit greater in patients with EF <50%) 2-vessel disease + significant proximal LAD stenosis + either EF <50% or ischemia on non-invasive testing.

Class IIa: In patients whom PCI will mitigate cardiac symptoms and who need elective non-cardiac surgery in the next 12 months Balloon angioplasty or bare-metal stent placement followed by 4 to 6 weeks of dual-antiplatelet therapy is indicated.

Beta blockers? Limitations in the perioperative beta-blocker literature include the following: Few randomized trials have examined the role of perioperative beta-blocker therapy Most trials are inadequately powered. Studies to determine the optimal type of beta blockers are lacking. Few studies addressing the optimal time at which beta blockers should be started in the perioperative period.

Figure 2. Proposed approach to the management of patients with previous percutaneous coronary intervention (PCI) who require noncardiac surgery, based on expert opinion. Fleisher L A et al. Circulation 2007;116:e418-e500 Copyright © American Heart Association What to do about those stents?

Figure 3. Proposed treatment for patients requiring percutaneous coronary intervention (PCI) who need subsequent surgery. Fleisher L A et al. Circulation 2007;116:e418-e500 Copyright © American Heart Association

For the full guidelines:

Pulmonary Pre-Operative Evaluation for Non-Pulmonary Surgery

Risk factors Age >50 Chronic lung disease Asthma Smoking OSA Pulmonary HTN Poor functional status Upper respiratory infection

Procedural risk factors Site of surgery Highest risk – thoracic, upper abdominal surgeries, AAA repair, ENT, neurosurgery Duration of surgery – greater than 3 to 4 hours Type of anesthesia?

Pulmonary Function Testing May be useful in the following cases: Identifying patients in whom risk of surgery does not justify the benefit Identifying patients at high risk that may benefit from aggressive pre-op optimization

Pulmonary Function Testing ACP recommendations: Do not obtain PFTs routinely to predict pulmonary post-op complications PFTs should NOT deny a patient surgery Obtain PFTs: In patients with COPD or asthma if clinical evaluation cannot determine is patient is at best baseline and would benefit from pre-op optimization In patients with dyspnea and exercise intolerance that remains unexplained after clinical evaluation

Chest X-Ray Add little to clinical evaluation of healthy patients Obtain CXR: In patients with known cardiopulmonary disease Unless CXR has been obtained in past 6 months In patients aged > 50 undergoing high risk procedures (thoracic/upper abdominal surgeries, AAA repair, ENT surgeries).

Arrouzullah Respiratory Failure Index Pre-operative predictorPoint value Type of surgery AAA27 Thoracic21 Neurosurgery, upper abdominal14 ENT11 Emergency surgery11 Albumin <3.0g/dL9 BUN >30 mg/dL8 Partially/fully dependent functional status7 History of COPD6 Age >

Arouzullah Respiratory Failure Index ClassPoint total%Resp Failure 1< >4026.6